Difficult-to-treat rheumatoid arthritis (D2T-RA) affects approximately 1 in 9 patients with RA worldwide, with nearly half of these cases demonstrating persistent inflammatory refractory RA (PIRRA), ...
CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback